
Pharma Cyclophosphamide Tablet By Harisons Life Science
Price: 118.00 INR / Strip
(100.00 + 18% GST)
Get Latest Price
Weight :
1.00
1 Pack Contains :
10
Minimum Pack Size :
10
In Stock
Product Specifications
| Suitable For | Other |
| Ingredients | Cyclophosphamide |
| Physical Form | Tablet |
| Recommended For | Cancer Treatment |
| Dosage | As prescribed by physician |
| Quantity | 30 Tablets |
| Storage Instructions | Store in a cool, dry place |
| Dosage Guidelines | Take with water; do not crush or chew |
| Function | Antineoplastic agent |
| Origin of Medicine | Allopathic |
| Indication | Breast cancer, leukemia, lymphoma, ovarian cancer, multiple myeloma |
| Pacakaging (Quantity Per Box) | 1 box (30 tablets) |
| Dosage Form | Oral |
| Salt Composition | Cyclophosphamide 50mg |
| Drug Type | Prescription |
| Supply Ability | 100000 Per Month |
| Delivery Time | 3 Days |
| Main Export Market(s) | Middle East |
| Payment Terms | Paypal |
| Main Domestic Market | All India |
| FOB Port | Surat |
| Sample Available | No |
| Weight | 1.00 |
| Gst | 18 |
| Is Returnable | 1 |
| Unit Type | Number |
| Mrp | 118.00 |
| Price | 100.00 |
| Brand Name | Pharma Cyclophosphamide Tablet |
| Currency | INR |
| Packsize | 10 |
| Mop | 10 |
| Delivery Time | 3 |
| Delivery Time Unit | 11 |
| GSTIN | 18% |
Company Details
Focusing on a customer-centric approach, Harisons Life Science has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from Harisons Life Science at Trade India quality-assured products.
Business Type
Exporter, Distributor, Supplier, Trading Company
Employee Count
12
Establishment
2012
Working Days
To
GST NO
24AAIFH0197B1ZR
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 24AAIFH0197B1ZR
Surat, Gujarat
Partner
Mr Nikhil
Address
Plot No. 1, First Floor Room No. 1/A, Shree Nilkantheshwar Society, Katargam Road, Near Gajera Circle, Surat, Gujarat, 395004, India
bicalutamide tablet in Surat
Report incorrect details

































